Compare PHR & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHR | NPCE |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 583.9M | 576.9M |
| IPO Year | 2019 | 2021 |
| Metric | PHR | NPCE |
|---|---|---|
| Price | $9.67 | $15.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 6 |
| Target Price | ★ $21.18 | $18.33 |
| AVG Volume (30 Days) | ★ 1.6M | 190.8K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.92 | 29.03 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $480,591,000.00 | $99,986,000.00 |
| Revenue This Year | $8.43 | $0.90 |
| Revenue Next Year | $5.10 | $24.46 |
| P/E Ratio | $207.20 | ★ N/A |
| Revenue Growth | 14.48 | ★ 25.13 |
| 52 Week Low | $7.77 | $7.56 |
| 52 Week High | $32.76 | $19.60 |
| Indicator | PHR | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 45.85 |
| Support Level | $8.00 | $15.40 |
| Resistance Level | $10.27 | $16.96 |
| Average True Range (ATR) | 0.60 | 0.77 |
| MACD | 0.14 | -0.09 |
| Stochastic Oscillator | 49.61 | 35.42 |
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.